Siga Technologies Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SIGA TECHNOLOGIES, and when can generic versions of SIGA TECHNOLOGIES drugs launch?
SIGA TECHNOLOGIES has two approved drugs.
There are ten US patents protecting SIGA TECHNOLOGIES drugs.
There are ninety-one patent family members on SIGA TECHNOLOGIES drugs in twenty-three countries and seven supplementary protection certificates in six countries.
Summary for Siga Technologies
International Patents: | 91 |
US Patents: | 10 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 2 |
Drugs and US Patents for Siga Technologies
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Siga Technologies | TPOXX | tecovirimat | CAPSULE;ORAL | 208627-001 | Jul 13, 2018 | RX | Yes | Yes | 9,339,466 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Siga Technologies | TPOXX | tecovirimat | CAPSULE;ORAL | 208627-001 | Jul 13, 2018 | RX | Yes | Yes | 8,124,643 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Siga Technologies | TPOXX | tecovirimat | CAPSULE;ORAL | 208627-001 | Jul 13, 2018 | RX | Yes | Yes | 8,039,504 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Siga Technologies | TPOXX | tecovirimat | CAPSULE;ORAL | 208627-001 | Jul 13, 2018 | RX | Yes | Yes | 7,737,168 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Siga Technologies Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Israel | 258239 | ⤷ Try a Trial |
France | 22C1022 | ⤷ Try a Trial |
Australia | 2011285871 | ⤷ Try a Trial |
Japan | 2013532729 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Siga Technologies Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2549871 | 122022000033 | Germany | ⤷ Try a Trial | PRODUCT NAME: TECOVIRIMAT ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/21/1600 20220106 |
1638938 | 122022000032 | Germany | ⤷ Try a Trial | PRODUCT NAME: TECOVIRIMAT ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/21/1600 20220106 |
1638938 | 2290024-5 | Sweden | ⤷ Try a Trial | PRODUCT NAME: TECOVIRIMAT OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/21/1600/001 20220107 |
1638938 | 301177 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: TECOVIRIMAT OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/21/1600/001 20220107 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.